Coloplast A/S (CLPBY) Insider Trading & Ownership $10.65 +0.03 (+0.28%) As of 04/17/2025 03:58 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock There is no recent insider trading on record for Coloplast A/S, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get CLPBY Insider Trade Alerts Want to know when executives and insiders are buying or selling Coloplast A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Coloplast A/S Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction1/27/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$11.66$1,001 - $15,00012/27/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$11.01$1,001 - $15,0005/17/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$12.56$1,001 - $15,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$12.07$1,001 - $15,000 (Data available from 1/1/2013 forward) CLPBY Insider Trading Activity - Frequently Asked Questions Which members of congress are trading Coloplast A/S? Josh Gottheimer (D-NJ) has bought shares of Coloplast A/S in the last year totaling $16,000. Josh Gottheimer (D-NJ) has sold shares totaling $8,000. Coloplast A/S Key ExecutivesMr. Kristian Villumsen (Age 54)President & CEO Compensation: $2.62MMr. Anders Lonning-Skovgaard (Age 52)Executive VP & CFO Compensation: $1.35MMr. Allan Rasmussen (Age 57)Executive Vice President of Global Operations Compensation: $1.18MMr. Nicolai Buhl Andersen (Age 55)Executive Vice President of Innovation Compensation: $1.14MMr. Paul Marcun (Age 57)Executive Vice President of Growth Compensation: $1.36MMr. Thomas Barfod (Age 54)Senior Controller & Employees Representative Director Compensation: $67.42kEllen BjurgertVice President of Investor RelationsDennis KaysenDirector of Corporate CommunicationsDorthe Ronnau (Age 58)Senior Vice President of People & Culture Mr. Alain MorvanSenior Vice President of Sales Europe More Insider Trading Tools from MarketBeat Related Companies Intuitive Surgical Insider Selling Edwards Lifesciences Insider Selling STERIS Insider Selling Zimmer Biomet Insider Selling Align Technology Insider Selling Smith & Nephew Insider Selling MSA Safety Insider Selling Enovis Insider Selling Cadre Insider Selling Establishment Labs Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (OTCMKTS:CLPBY) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Coloplast A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
